SEARCH

SEARCH BY CITATION

References

  • 1
    Faich GA. Adverse drug-reaction monitoring. N Engl J Med 1986;65:448453.
  • 2
    Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004;113:771775.
  • 3
    Szczeklik A, Gryglewski R, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1:6769.
  • 4
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913921.
  • 5
    Szczeklik A, Niżankowska E, Bochenek G, Nagraba K, Mejza F, Świerczyńska M. Safety of specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219225.
  • 6
    Christie P, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:10251029.
  • 7
    Dahlén B, Kumlin M, Morgolskee DJ, Larsson C, Blomqvist H, Williams VC et al. The leukotriene receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993;6:10181026.
  • 8
    Nasser SM, Lee TH. Leukotrienes in aspirin-sensitive asthma. In: SzczeklikA, GryglewskiRJ, VaneJR, editors. Eicosanoids, aspirin and asthma. New York, Basel, Hong Kong: Marcel Dekker Inc., 1998:451472.
  • 9
    Kasper L, Sladek K, Duplaga M, Bochenek G, Liebhart J, Gladysz U et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003;58:10641066.
  • 10
    Hedman J, Kaprio J, Poussa T, Neminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717722.
  • 11
    Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin-intolerant asthma (aspirin-induced asthma) in Australian asthmatic patients. Thorax 2002;57:569574.
  • 12
    Jenkins Ch, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. Br Med J 2004;328:434440.
  • 13
    Kowalski ML, Ptasińska A, Jędrzejczak M, Bieńkiewicz B, Cieślak M, Grzegorczyk J et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocyte is specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 2005;60:11391145.
  • 14
    Sanz ML, Gamboa P, De Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136:5872.
  • 15
    Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276284.
  • 16
    Niżankowska E, Szczeklik A. Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin intolerant patients with asthma. Ann Allergy 1989;63:159164.
  • 17
    Stevenson DD. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74:617622.
  • 18
    Szczeklik A, Niżankowska E. Pharmacological agents in bronchial provocation tests. In: AllegraL, BragaPB, Dal NegroR, editors. Methods in astmology. Berlin, Germany: Springer Verlag, 1993:253264.
  • 19
    Niżankowska E, Bestyńska-Krypel A, Ćmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863869.
  • 20
    Dahlén B, Zetterström O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990;3:527534.
  • 21
    Bochenek G, Niżankowska E, Szczeklik A. Testing for aspirin hypersensitivity. Allergy 2002;57:562565.
  • 22
    Stevenson DD, Simon RA, Zuraw BL. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: AdkinsonNF, BochnerB, YungingerJW, HolgateST, BusseWW, editors. Middleton’s allergy. Principles and practice. Mosby: St Louis, 2003:16951710.
  • 23
    Bianco S, Robushi M, Patrigni G. Aspirin induced tolerance in aspirin-induced asthma detected by a new challenge tests. J Med Sci 1977;5:129130.
  • 24
    Schmitz-Schumann M, Schaub E, Virchow C. Inhalative provocation mit lysin-azetylzalizylsaure bei analgetica-asthma syndrome. Prax Pneumol 1982;36:1721.
  • 25
    Philips GD, Foord R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatibility, absence of late-phase reaction, and the role of histamine. J Allergy Clin Immunol 1989;84:232241.
  • 26
    Melillo G, Balzano G, Bianco S, Dahlen B, Godard P, Kowalski ML et al. report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-Induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Allergy 2001;56:899911.
  • 27
    Ortolani C, Mirone C, Fontana A, Folo GC, Miadonna A, Montalbetti N et al. Study of mediators of anaphylaxis in nasal provocation in intolerant rhinitic patients. Ann Allergy 1987;59:106112.
  • 28
    Patriarca G, Nucera E, Direnzo V, Schiaviano D, Pellegrino S, Fais G. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy 1991;67:6062.
  • 29
    Schapowal A, Schmitz-Schumann M, Szczeklik A, Bruijnzel P, Hansel T, Virchovsen Chr. Lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998;101:581586.
  • 30
    Milewski M, Mastalerz L, Niżankowska E, Szczeklik A. Nasal provocation test for diagnosis of aspirin-induced asthma. J Allergy Clin Immunol 1998;101:581586.
  • 31
    Casadevall J, Ventura PJ, Mullol J, Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax 2000;55:921924.
  • 32
    Alonso-Llamazares A, Martinez-Cocera C, Dominiquez-Ortega J, Robledo-Echarren T, Cimarra-Alvarez M, Mesa del Castillo M. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy 2002;57:632635.
  • 33
    Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstein IL, Nicklas RA. The diagnosis and management of anaphylaxis: an updated practice parameter. Joint Task Force on Practice Parameters presenting by American Academy of Allergy, Asthma and immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2005;115(Suppl. 2):S483S523.
  • 34
    Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006;61:316320.